Whereas the number of individuals in the United States with Alzheimer's and related dementias (referred to in this preamble as Alzheimer's ) is as high as 5,400,000, which is more than double the number in 1980; Whereas based on the trajectory of Alzheimer's, as many as 16,000,000 individuals in the United States may have Alzheimer’s by 2050; Whereas the increasing prevalence of Alzheimer’s and other dementias is a global health crisis that afflicts an estimated 46,780,000 individuals worldwide as of August, 2015 and may afflict more than 131,000,000 individuals by 2050; Whereas Alzheimer’s is a leading cause of death in the United States with data indicating that more than 500,000 deaths each year are attributable to the disease; Whereas Alzheimer's is the only disease among the top 10 causes of death in the United States without an effective means to prevent, slow, or stop; Whereas Alzheimer’s places an enormous financial strain on families, the health care system, and State and Federal budgets; Whereas the Medicare program under title XVIII of the Social Security Act ( 42 U.S.C. 1395 et seq.) and the Medicaid program under title XIX of the Social Security Act ( 42 U.S.C. 1396 et seq.) are estimated to bear more than two-thirds of the total costs of this care in 2016; Whereas a RAND Corporation study published in 2013 and commissioned by the National Institute on Aging found that Alzheimer’s is the costliest disease in the United States, costing more than cancer and heart disease; Whereas in 2015, an estimated 15,800,000 family members and friends of individuals with Alzheimer's provided those individuals with 18,100,000,000 hours of unpaid care, an amount valued at more than $221,300,000; Whereas Alzheimer’s disease has a disproportionate impact on many populations including women, African-Americans, and Latinos; Whereas the global cost of Alzheimer’s exceeds $818,000,000,000 each year, an amount equal to approximately 1 percent of the world’s gross domestic product